litlas
HomeLibrarySearchHistorySettingsPlans
Log inCreate account
HomeLibrarySearchHistorySettingsPlans
Log inCreate account

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

Authors: Taofeek K. Owonikoko, Huifeng Niu, Kristiaan Nackaerts, Tibor Csőszi, Gyula Ostoros, Z. Mark, Christina S. Baik, Anil A. Joy, C. Chouaïd, Jesus Corral Jaime, Vı́tězslav Kolek, Margarita Majem, Jaromı́r Roubec, Edgardo S. Santos, Anne C. Chiang, Giovanna Speranza, Chandra P. Belani, Alberto Chiappori, Manish R. Patel, Krisztina Czebe, Lauren A. Byers, Brittany Bahamón, Cong Li, Emily Sheldon‐Waniga, Eric Kong, Miguel Williams, Sunita Badola, Hyunjin Shin, Lisa Bedford, Jeffrey Ecsedy, Matthew Bryant, Siân Jones, John K. Simmons, E. Jane Leonard, Claudio Dansky Ullmann, David R. Spigel - Journal of Thoracic Oncology 2019 cited by 147

litlas

Research-grade literature search and reference management for serious knowledge work.

HomeLibrarySearchHistorySettingsPlans
BlogAuthorsData sourcesFor librariansAPI documentationLegal noticeTerms of servicePrivacy policy